Search Orphan Drug Designations and Approvals
-
Generic Name: | idebenone |
---|---|
Date Designated: | 05/22/2009 |
Orphan Designation: | Treatment of mitochondrial myopathy, encephalopathy, lactic acidosis with stroke-like episodes syndrome (MELAS) |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
Date Designation Withdrawn or Revoked: | 07/22/2019 |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Santhera Pharmaceuticals (Switzerland) Ltd. 25 Hammerstrasse Liestal, Basel-Landschaft Switzerland The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-